Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered cartilage implant made from allogeneic chondrocytes. When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints. #cartilagerepair #cartilageregeneration #celltherapy #kneerepair #osteoarthritis
| Website | https://www.vanarix-cartilage-regeneration.ch/ |
| Employees | 6 (2 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology Research |
| Keywords | Orthopedics, Cartilage Regeneration, Bone And Joint, Cartilage Repair, Cell Therapy, Tissue Engineering, Regenerative Medicine, Orthopedic Implants, Joint Repair, Arthritis Treatment, Medical Implants, Surgical Implants, Biological Implants |
| Competitors | Stryker, Integra LifeSciences, MiMedx, Receptos, a wholly-owned subsidiary of Celgene, Orthofix, Acelity, Anika, Savara Inc., Athersys, MediWound Ltd. +31 more (view full list) |
Looking for a particular Vanarix employee's phone or email?
2 people are employed at Vanarix.